MORGAN STANLEY

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Back to FULC Full portfolio

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,329,492

-$543,701 QoQ

Shares Held

173,337

+4.7% QoQ

Ownership

0.260%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 168 holders

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 84.87108926541939.ToString("F0")% Shared 0.ToString("F0")% None 15.128910734580614.ToString("F0")%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. FULC ranks #237 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

All Filings in FULC

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,329,492	173,337	+4.7%	Shares	Defined	2026-05-15
2025-12-31	$1,873,193	165,623	-32.1%	Shares	Defined	2026-05-27
2025-09-30	$2,243,279	243,835	-22.4%	Shares	Defined	2026-05-27
2025-06-30	$2,163,139	314,410	+10.1%	Shares	Defined	2025-08-15
2025-03-31	$822,523	285,599	-81.4%	Shares	Defined	2025-05-15
2024-12-31	$7,199,138	1,531,732	+336.8%	Shares	Defined	2025-05-15
2024-09-30	$1,251,943	350,685	-71.6%	Shares	Defined	2025-05-14
2024-06-30	$7,655,838	1,234,813	+6.7%	Shares	Defined	2025-05-14
2024-03-31	$10,923,370	1,157,137	-5.1%	Shares	Defined	2024-10-17
2023-12-31	$8,228,647	1,219,059	+33.7%	Shares	Defined	2024-08-16
2023-09-30	$4,048,703	911,871	-17.4%	Shares	Defined	2023-11-15
2023-06-30	$3,642,781	1,103,874	-5.0%	Shares	Defined	2023-08-14
2023-03-31	$3,312,744	1,162,368	-1.0%	Shares	Defined	2023-05-15
2022-12-31	$8,543,884	1,173,611	-2.2%	Shares	Defined	2023-02-14
2022-09-30	$9,710,440	1,200,302	+1.8%	Shares	Defined	2022-11-14
2022-06-30	$5,776,880	1,178,956	+6.4%	Shares	Defined	2022-10-27
2022-03-31	$26,214,226	1,108,424	+1137.8%	Shares	Defined	2022-10-27
2021-12-31	$1,584,137	89,550	+5.3%	Shares	Defined	2022-02-14
2021-09-30	$2,398,157	85,011	+17.6%	Shares	Defined	2021-11-15
2021-06-30	$757,659	72,296	+6.6%	Shares	Defined	2021-08-23
2021-03-31	$798,741	67,805	-31.4%	Shares	Defined	2021-05-17
2020-12-31	$1,158,095	98,898	+212.5%	Shares	Defined	2021-02-16
2020-09-30	$250,975	31,649	-22.9%	Shares	Defined	2020-11-13
2020-06-30	$750,803	41,050	+40.8%	Shares	Defined	2020-08-14
2020-03-31	$348,026	29,148	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.